Tobias B.
- Country
- Germany
- Department
- Klinik für Innere Medizin II Gastroenterologie, Hepatologie, Endokrinologie und Infektiologie
Research Overview
- Phase III Double-Blind, Randomized, Placebo-Controlled Study of Norursodeoxycholic Acid in Primary Sclerosing Cholangitis Patients
- Phase 3 Evaluation of Pegozafermin Efficacy and Safety in Metabolic Dysfunction-Associated Steatohepatitis with Compensated Cirrhosis
- Evaluation of Pegozafermin Efficacy and Safety in Patients with Metabolic Dysfunction-Associated Steatohepatitis and Fibrosis: A Phase 3 Clinical Trial
Data & Insights
Has run more than one trial at 60 of 117 partner sites.
Specializations
Liver Disease Management
This investigator specializes in treating chronic liver conditions, with particular emphasis on Primary Sclerosing Cholangitis (PSC) and its innovative therapeutic approaches. Their research encompasses evaluation of novel treatments using compounds like norucholic acid and norursodeoxycholic acid.
- PSC Treatment Development
- Bile Acid Therapeutics
- Disease Progression Prevention
Their work focuses on establishing new therapeutic options for managing chronic cholestatic liver diseases.
Metabolic Liver Disorders
The investigator conducts research in Metabolic Dysfunction-Associated Steatohepatitis (MASH), investigating advanced treatments for patients with varying degrees of liver fibrosis and cirrhosis. Their work includes evaluation of pegozafermin as a therapeutic agent.
- MASH/NASH Management
- Liver Fibrosis Treatment
- Compensated Cirrhosis Care
The research encompasses both early-stage liver disease and advanced cirrhotic conditions.
Clinical Outcomes Research
This expert focuses on long-term clinical outcomes in liver diseases, conducting studies to evaluate treatment efficacy through histological assessment and composite clinical endpoints. Their research emphasizes disease modification and progression prevention.
- Liver Histology Analysis
- Treatment Safety Evaluation
- Disease Progression Markers
Their studies incorporate comprehensive assessment of therapeutic interventions in chronic liver conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.